A top-20 pharma to utilize Xyntek-Antares serializing for China

8 December 2014
china-big

A top 20 multi-national pharmaceutical research and manufacturer is utilizing the Xyntek-Antares solution and services to implement an expedited serialization packaging solution in order to meet product serialization requirements for the Chinese market.

The requirements established for serialization by the Chinese government differ from the standards used in the USA. While each pharmaceutical packaging line generally possesses a unique serialization solution, this project and its serialization solution were specifically designed to meet requirements set for the Chinese Market. The Chinese pharmaceutical serialization market is a unique regulatory commission which utilizes the government-controlled EDMC serialization codes. These codes must be requested by the manufacturer and reported back to the government regulatory body when the product is fully packed and serialized.

To meet the aggressive timelines and requirements for the project, Xyntek-Antares implemented the Antares Manual Station. The module manages both the commissioning and checking of the pre-printed serial numbers on cartons, as well as the production and verification of serialized labels for cases. The compact module is fitted with bundled software to achieve the client's requirements, including:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical